The explorations of the TIME in the 4T1 tumor model revealed that RT combined with Y332D therapy significantly promoted DCs maturation and macrophage polarization toward an M1‐like phenotype, as well as enhanced the abundance, activation, proliferation, and cytotoxicity of CD8+ T cells and the activation of NK cells within the TME. The gene discussed is CD8A; the disease is neoplasm.